As a protective factor in epilepsy, the IL-1 receptor antagonist anakinra can be used as a treatment for refractory epilepsy (Yamanaka et al., 2021), and vascular endothelial growth factor is considered an attractive target for epilepsy treatment (Lange et al., 2016). The gene discussed is VEGFA; the disease is epilepsy.